Literature DB >> 6913409

Measurement of urinary kallikrein activity. Species differences in kinin production.

F Alhenc-Gelas, J Marchetti, J Allegrini, P Corvol, J Menard.   

Abstract

A sensitive, specific radioimmunoassay for kinins has been developed, which is able to detect 1.5 pg bradykinin or 3 pg lysyl-bradykinin (Lys-bradykinin). 50% displacement in the standard curve was obtained with 10 pg bradykinin or 15 pg Lys-bradykinin in 0.6-ml incubates. The antisera, raised against bradykinin, recognized well Lys-bradykinin and methionyl-lysyl-bradykinin (Met-lys-Bradykinin), but cross-reacted 0.4% or less with bradykinin fragments. Kininogen cross-reacted only 0.2%. The radioimmunoassay and kininogen from several species were used in the measurement of human and rat urinary kallikrein activity. The peptide generated by hydrolysis of the substrates by rat or human urines was characterized by radioimmunoassay in two different systems: polyacrylamide gel electrophoresis and carboxymethyl cellulose chromatography. Both urines did not produce the same kinin: the kinin produced by human urine migrated like Lys-bradykinin, whereas the kinin produced by rat urine migrated like bradykinin. This gives evidence of differences in the specificity between kinin-forming enzymes in rat and human urines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6913409     DOI: 10.1016/0304-4165(81)90262-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

2.  Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.

Authors:  B A Katz; B Liu; M Barnes; E B Springman
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

3.  Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

Authors:  D C Pimenta; J Chao; L Chao; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.

Authors:  P Meneton; M Bloch-Faure; A A Hagege; H Ruetten; W Huang; S Bergaya; D Ceiler; D Gehring; I Martins; G Salmon; C M Boulanger; J Nussberger; B Crozatier; J M Gasc; D Heudes; P Bruneval; T Doetschman; J Ménard; F Alhenc-Gelas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

5.  Kallikrein rK10-induced kinin-independent, direct activation of NO-formation and relaxation of rat isolated aortic rings.

Authors:  I Wassdal; R Hull; V P Gerskowitch; T Berg
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways.

Authors:  J P Girolami; J L Bascands; C Pécher; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

7.  Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone.

Authors:  K Tomita; J J Pisano; M A Knepper
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.

Authors:  Daniel C Pimenta; Sandro E Fogaça; Robson L Melo; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment.

Authors:  J Marchetti; M Imbert-Teboul; F Alhenc-Gelas; J Allegrini; J Menard; F Morel
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

10.  Role of vasopressin in regulation of renal kinin excretion in Long-Evans and diabetes insipidus rats.

Authors:  M L Kauker; J T Crofton; L Share; A Nasjletti
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.